Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Myopharm Limited

Clinical trials sponsored by Myopharm Limited, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Triple-Drug combo aims to improve diabetes control and weight loss Results expected Sep 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

Triple-Drug combo aims to improve diabetes control and weight loss

Disease control Not yet recruiting

This study tests a new combination drug called TriGlytza-01 in overweight adults with type 2 diabetes whose blood sugar is not well controlled by metformin alone. The trial compares TriGlytza-01 to standard metformin over 16 weeks, measuring safety, blood sugar levels, and body w…

Phase 2 • Sponsor: Myopharm Limited • Aim: Disease control

Last updated Jul 10, 2026 00:00 UTC